« Decentralization of HIV care in subsaharan Africa: lessons for resource allocation» Dr. Fred Eboko, IRD French Research Institute for the Development,

Slides:



Advertisements
Similar presentations
Evaluation of access to ART and the health care system in Cameroon ANRS Research Program in Social Sciences Dr. Fred Eboko, IRD UMR 912 INSERM-IRD U2 Marseille.
Advertisements

Contribution of Economics to Operational Research for Evaluation of Scaling Up Access to HIV Care & Treatment in Developing Countries Presentation by Pr.
Evaluation of access to ART and decentralization of health care delivery in Cameroon French Agency for AIDS Research (ANRS) Program in Economic & Social.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
Role of the HIV/AIDS community in science & regulatory advocacy Nikos Dedes European AIDS Treatment Group 22 July 2014, Melbourne.
Churches and Health Care in DR Congo by Leon Kintaudi ECC-DOM Medical Director.
Sexual activity and risk behaviors among HIV-infected patients initiating ART in rural district hospitals in Cameroon Preliminary results of a 24-month.
Title: PEOPLE LIVING WITH HIV/AIDSIN EGYPT: ROLE OF COMMUNITY PHARMACIST Authors: Nahla Maher Hegab Pharmacy graduate. Institution: College of pharmacy,
Brazzaville, Congo 5-7 March 2014
Working Together to Improve Global Health
Comprehensive M&E Systems
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
HIV and the Financial Crisis Academic Council Debate on the Financial Crisis and Public Health Robert Greener, April 30, 2009.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
1 Situation of Current ARV Treatment in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
At What Cost? U.S. Leadership in Global Health in an Era of Austerity Dr. J. Stephen Morrison Senior Vice President; Director, Global Health Policy Center.
Track A: Basic Science This track highlighted all aspects of HIV structure, replication, and the host immune responses and led to a greater understanding.
Primary health care and District health. Primary healthcare Definition Levels of referral Free health care – who qualifies? Physiotherapists are first.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Human Capacity Development in Cote d’Ivoire: A Collaboration for Pre-Service Training in HIV, TB and Malaria between the Elizabeth Glaser Pediatric AIDS.
Overview Burkina--- ART Population: 11 millions Prevalence: 6.6% (surveillance data) Estimate of 650,000 PLWHA 300 peoples with red cross 2000 people to.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
The Global Fund- structure, function and evolution February 18, 2008.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
Joan Holloway Vice President, Global Health Initiatives Multidisciplinary Care Team Delivery of Integrated HIV Services.
“Time is costly”: Modelling the macro-economic impact of scaling up access to antiretroviral treatment for HIV/AIDS Jean-Paul Moatti*, Bruno Ventelou*,
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
Svetlana Spassova, MD Ministry of Health, Bulgaria Chisinau
Socio-behavioral Issues in Aging and HIV: Critical for Success in Prevention and Care Sherry Deren Center for Drug Use and HIV Research, NYU College of.
Funding Universal Access through a “Global Health Charge” on alcohol and tobacco: feasibility in the 20 countries with the largest HIV epidemics Dr Andrew.
Catastrophic healthcare expenditures and working difficulties with HIV in low-resource settings: the Cameroonian experience Jean-Paul Moatti 1,2,3, Sandrine.
IRSS – Centre Muraz : A collaborative research initiative for the promotion of Health in Africa Maxime Koiné DRABO MD, MPH, PhD.
Ministry of Health, Mozambique
Evaluation of access to ART and decentralization of health care delivery in Cameroon French Agency for AIDS Research (ANRS) Program in Economic & Social.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
Co-infections TB/HIV in prison Côte d’Ivoire Case study Doctor J-M MASUMBUKO ESTHER Coordinator in Côte d’ivoire 24 July th IAC,
The National HIV Counselling and Testing Campaign and Treatment Expansion in South Africa: A return on investments in combination prevention XIX International.
1 Partnering to Strengthen Local Efforts Can Help Us Get to Six Million on ART Anja Giphart, MD MPH Vice President, Program Implementation Elizabeth Glaser.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
WORLD BANK INSTITUTE AIDS LEADERSHIP PROGRAM Arlette Campbell White Elizabeth Ashbourne.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Multi-country study on drug supply and distribution activities of faith-based supply organizations in sub-Saharan African countries, 2003 Sophie Logez.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
Facility supervision by the District Health Teams (DHTs) in Rwanda Track1 Meeting Maputo, Mozambique, August 10 th -12 th Dr. Ruben Sahabo.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
Presentation to the Health Portfolio Committee Presentation to Health Portfolio Committee Free State Department of Health 15 APRIL 2003.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
Aids treatment on the field Experiences from CAMEROON Swiss AIDS platform Aidsfocus Bern, April 2004 Béata UMUBYEYI.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
Dr Kokou AGOUDAVI, MD, PHPM Chief Officer NCD Ministry of Health TOGO
How differentiated care supports “Tx all” and Dr
Country presentations Thailand Dr
Zimbabwe’s shift towards treat all: national country context
UNITAID Overview Joint Consultation on Seasonal Malaria Chemoprevention Ouagadougou, Burkina Faso, February 2017.
UNIVERSAL ACCESS A Perspective From Rwanda
Current harm reduction program at outreach
Expanding ARV treatment in developing countries: Issues and Prospects
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
China 2010 UNGASS Country Progress Report
DECREASES DONOR FUNDING WHAT SHALL BE DONE IF TO FIGHT HIV DRASTICALLY
EDUCATION SECTOR STRATEGIC PLAN FOR HIV/AIDS PREVENTION
Presentation transcript:

« Decentralization of HIV care in subsaharan Africa: lessons for resource allocation» Dr. Fred Eboko, IRD French Research Institute for the Development, Marseille. France Session : « The Impact of the Economic Crisis on HIV Programs: Is Integration to Health Systems the Solution? » 6th IAS Conference on HIV Pathogenis, Treatment and Prevention Rome – July 2011 Ministère de la Santé Publique du Cameroun

“ Financing a sufficient and sustained response to the HIV epidemic in low-and middle-income countries has emerged as one of the world’s greatest health and development challenges, and one that will be with us for the foreseeable future. International assistance from donor governments, through bilateral aid and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and other financing channels such as UNITAID (the international drug purchase facility) is a critical part of this response” (Kaiser Family & Unaids, 2010: 1) A challenge

Background (1/2) A scientific answer to the challenges of Public Health Context  Continuous decrease in prices of ARV in Cameroon -1999: $ /patient/month : patients under ART -2005: 2,5$/patient/ : patients unnder ARV -May 1st 2007, ART Free Access -December 2009 : patients treated 46.5% of eligible patients in Cameroon.  A new policy of decentralization  A national and international issue An objective  Evaluate an ongoing process and propose objective insights

Background (2/2)  ANRS research program includes 4 projects : –Decentralization of ARV access in Africa: Evaluation of the treatment of patients on ARV in district hospitals using a streamlined follow-up approach (Trial Esther/STRATALL) –Impact of the Cameroonian access to an ARV program on the treatment and living conditions of the HIV infected population (EVAL) –The problem of access to ART in Cameroon. Issues, Advances, Limits and Perspectives of health care decentralization (POLART) –Scaling up and procurement of drugs and biological monitoring tools

Objectives Evaluation of the Impact of access to ARV on the living conditions of PLWHA –Adherence and medical effectiveness –Quality of Life –Risky sexual behaviors Evaluation of the impact on the health system –Impact on medical knowledge and practice –Changes introduced in the organization of Health Care Methods Quantitative –Cross-sectional survey among 3151 HIV+ adults and 317 healthcare personnel included in 27 treatment centers –Data capture of treatment centers characteristics Qualitative : Semi-structured interviews of patients and healthcare staff EVAL ANRS Pr. Moatti (Inserm Marseille), Pr. Abega (UCAC Yaoundé)

A relatively high quality of healthcare in decentralized treatment centers –Average increase in CD4 count for patients treated for at least 6 months not different from that found at a national level: 12.5 cells /µL/ month –Significantly higher adherence for those patients treated at district treatment centers: 61.2% of patients have a high adherence score versus 44.5% in centralized treatment centers –Physical Quality of Life comparable to that found at central service level and a better Mental Quality of Life  FEASABILITY DEMONSTRATED FOR DECENTRALISING ART TREATEMENT EVAL ANRS – Main results

Trial Esther/STRATALL ANRS Pr. Delaporte (IRD Montpellier), Dr Kouanfack (HCY Ydé) Volet sciences sociales : Pr. Moatti (INSERM), Pr. Abega (†) /C. Abé (UCAC) « Decentralization of ARV access in Africa: Evaluation of the treatment of patients on ARV in district hospitals using a streamlined follow-up approach (STRATALL)” Social Sciences Objectives  Evaluation of the streamlined follow-up on 4 aspects: - Quality of Life -Adherence -Socio-economic feasability - Behavioral Disinhibition

Results Proportion of patients susceptible to transmit HIV among those having sexual activity during follow-up (n=361)

POLART ANRS Dr F. Eboko (IRD/FPAE), Pr. Sindjoun (GRAPS, Un. Ydé 2) Objectives -Identify actors involved in the decentralization of ARV treatment (institutions, local associations of PLWHA, international Cooperation) -Analyze their roles and structures -Analyze the effect of external partners’ involvement in the process of decentralization -Understand the qualitative factors which differentiate health care quality from one site to another Methods -Qualitative Study :  Interviews with patients : Therapeutic Itineraries and biographies  Interviews with the different actors (institutions, local associations of PLWHA, international Cooperation)

Elements of analysis Decentralization can come in a variety of forms: deconcentration, devolution, privatization Decentralization of access to ARV in Cameroon corresponds in a general way to a process of deconcentration The involvement of external actors in certain provinces or health facilities leads to other types of decentralization which are not exclusive from each other: -Between devolution and privatization: the hospital “Fondation Suisse de Petté” -Between decentralization and saturation: The intervention of the Swiss MSF in Douala  Reinforcement of the relative autonomy of UPEC at Nylon and of CMA at Congo 2 but saturation of services due to the reputation and quality of health care/

The contribution of the Cameroonian program to international questions Long term and financial sustainability of free access to medicines? Optimal degree of decentralization to enable scaling-up? New distribution of tasks between healthcare providers (“task shifting”) to find solutions to the Human Resources crisis? Impact of AIDS programs on the fight against other diseases (tuberculosis, malaria) and on the global reinforcement of the health care system?

From economics to politicis? Multidisciplinary proposals. Work in progress « Cameroun, Burkina Faso, Botswana AIDS Policy in Africa. A Comparative Approach ». ( ) (Eboko, Owona N., Enguéguélé, 2009) Governance and AIDS in Africa. Barriers, limits and perspectives (Senegal, Burkina Faso, Cameroon, Cote d’Ivoire) ». Learning from defeat and success in Funding and Governance …

Thanks Patients AIDS NGOs in Cameroon Healthcare professionals and personnel of Healthcare facilities Ministry for Public Health in Cameroon National AIDS Committee Regional Delegation of Public Health National Agency for research on AIDS and Hepatitis B & C (ANRS, France) French Cooperation (SCAC, Yaounde) AIDES

The teams Cameroon L’UCAC : –Institut de Recherche Socio-anthropologique (IRSA) Dir. : Pr. S.C. Abega/ Pr C. Abé –Groupe d’Études, de Recherche et de Conseil sur l’Insertion Sociale (GERCIS) Dir. : Pr. R. Nantchouang L’Université de Yaoundé 2 –Groupe de Recherches Administratives, Politiques et Sociales (GRAPS) Dir. : Pr. L. Sindjoun L’Université de Yaoundé 1 : –Center for Applied Social Sciences – Research and Training (CASS-RT) Dir. : Pr. P. Nkwi Fondation Paul Ango Ela pour la géopolitique en Afrique Centrale (FPAE) Yaoundé) Dir. : Mme K. Ango Ela France L’UMR 912 INSERM-IRD-U2 –( Dir. : Pr. J.-P. Moatti